ZIO-201-T and doxorubicin
IPM1002
Phase 1 small_molecule completed
Quick answer
ZIO-201-T and doxorubicin for Advanced Cancer is a Phase 1 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alaunos Therapeutics
- Indication
- Advanced Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed